Table 2. Summary of functional experiments for based compounds evaluated at the mouse melanocortin receptors.
mMC1R | mMC3R | mMC4R | mMC5R | Selectivity | |||||
---|---|---|---|---|---|---|---|---|---|
Compound | Agonist EC50 (nM) | Agonist EC50 (nM) | Agonist EC50 (nM) | Agonist EC50 (nM) | Ratios | ||||
Mean±SEM | Fold Diff. | Mean±SEM | Fold Diff. | Mean±SEM | Fold Diff. | Mean±SEM | Fold Diff. | 1R: 3R:4R:5R | |
NDP-MSH | 0.03±0.01* | 0.24±0.01* | 0.46±0.04* | 0.31±0.03* | 1:9:18:12 | ||||
α-MSH | 0.15±0.05 | 0.76±0.05 | 4.0±0.9 | 0.59±0.03 | 1:5:28:4 | ||||
Ɣ-MSH | 1090±300 | 34.6±4.0 | 869±66 | 35.1±18.7 | 31:1:25:1 | ||||
1 | 14.1±2.6* | 1 | 55.5±12.2* | 1 | 13.7±1.9* | 1 | 9.8±2.7* | 1 | 1:4:1:1 |
2 | 26.2±9.9 | 0.5 | 47.4±12.7 | 1 | 5.7±2.9 | 2 | 2.1±0.3 | 5 | 13:23:3:1 |
3 | 24.9±5.9* | 0.6 | 30.9±7.5* | 2 | 18.5±2.9* | 0.7 | 3.9±1.3* | 2 | 6:8:5:1 |
4 | 5.7±.7 | 2 | 107±66 | 0.5 | 74.1±14.1 | 0.2 | 52.4±10.3 | 0.2 | 1:19:13:9 |
5 | 16.4±4.7* | 0.9 | 27.2±5.2* | 2 | 14.5±2.7* | 0.9 | 4.9±1.2* | 2 | 3:6:3:1 |
6 | 4.4±0.6* | 3 | 20.2±4.0* | 3 | 9.2±1.0* | 1 | 3.8±0.9* | 2 | 1:5:2:1 |
7 | 6.4±1.5* | 2 | 10.1±2.5* | 5 | 3.6±0.5* | 4 | 3.1±0.6* | 3 | 1:3:1:1 |
8 | 12.6±3.8 | 1 | 22.7±3.7 | 2 | 7.3±2.1 | 2 | 4.0±0.2 | 2 | 3:6:2:1 |
AlphaScreen® assays were performed to determine relative potency of compounds to induce cAMP signaling. The reported errors are the standard error of the mean (SEM) determined from at least three independent experiments. Changes less than 3-fold were considered to be within the inherent experimental assay error.
denotes six or more independent experiments.